Clinical Trial Update: Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treosulfan-based conditioning for allogeneic stem cell transplantation in lymphoid malignancies is being updated. The study includes No…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: Sheba Medical Center | Conditions: Non Hodgkin Lymphoma, Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN